(Q38037123)

27 August 2017

title

An update on bronchodilators in Phase I and II clinical trials (English)

1 reference

27 August 2017

main subject

phase I clinical trial

0 references

2

Paola Rogliani

1 reference

27 August 2017

Mario Cazzola

1

1 reference

27 August 2017

Andrea Segreti

series ordinal

3

1 reference

27 August 2017

Maria Gabriella Matera

series ordinal

4

1 reference

27 August 2017

language of work or name

English

0 references

publication date

23 August 2012

1 reference

Expert Opinion on Investigational Drugs

27 August 2017

published in

1 reference

27 August 2017

volume

21

1 reference

27 August 2017

issue

10

1 reference

27 August 2017

page(s)

1489-1501

1 reference

Global strategy for asthma management and prevention: GINA executive summary.

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Novel long-acting bronchodilators for COPD and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Emerging inhaled bronchodilators: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Novel bronchodilators in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Novel bronchodilators for the treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

THRX-198321 is a bifunctional muscarinic receptor antagonist and beta2-adrenoceptor agonist (MABA) that binds in a bimodal and multivalent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Multivalent dual pharmacology muscarinic antagonist and β₂ agonist (MABA) molecules for the treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Triple therapy for the management of COPD: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Adherence to Prescribed Treatment for Asthma: Evidence from Pharmacy Benefits Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Pharmacology and therapeutics of bronchodilators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Inhaled combination therapy with long-acting beta 2-agonists and corticosteroids in stable COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Safety of long-acting β agonists for the treatment of asthma: clearing the air.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

MDR-TB and XDR-TB: drug resistance and treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Symptom variability in patients with severe COPD: a pan-European cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

Once-daily inhaled corticosteroids in mild to moderate asthma: improving acceptance of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.710602

10.1517/13543784.2012.710602

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference